NASDAQ$TCMD
Tactile Systems Technology Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Revenue increased driven by strong sales of airway clearance products, but operating and net income decreased due to increased operating expenses.
Tactile Systems Technology, Inc. reported a 17% increase in revenue for the second quarter of 2022, driven by airway clearance product sales. However, the company experienced an operating loss and a net loss, compared to operating income and net income in the same quarter of the previous year.
- Total revenue increased 17% year-over-year to $59.6 million.
- Revenue from airway clearance products was $8.0 million.
- Operating loss was $4.1 million, compared to $0.1 million in the second quarter of 2021.
- Net loss was $4.6 million, compared to net income of $1.3 million in the second quarter of 2021.
Headline financials
Revenue & EPS history
Tactile Systems · Revenue · Quarterly
$59.6M
Revenue by segment
Tactile Systems · $59.6M total across 2 segments · Q2 2022
- Lymphedema products$51.6M—86.6%
- Airway clearance products$8.01M—13.4%
Forward guidance
The Company now expects full year 2022 total revenue in the range of $238.0 million to $242.0 million, representing growth of approximately 14% to 16% year-over-year.
Tailwinds
- Improving the productivity of recently hired and promoted sales representatives
- Furthering the successful introduction of our new products
- Supporting our AffloVest channel partners
- Positioning ourselves for improved profitability
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
+3.1%
Avg return
Earnings day
+3.6%
Avg return
5 days after
+5.9%
Avg return
30 days after
64%
29 / 45 earnings
Positive
+40.6%
Q3 2025
Best reaction
-29.0%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +7.2% | +14.5% | +12.2% | |
| Q4 2025 | +17.4% | +2.2% | -7.0% | |
| Q3 2025 | +40.6% | +57.6% | +70.0% | |
| Q1 2025 | -29.0% | -31.6% | -27.5% | |
| Q4 2024 | -13.3% | -16.6% | -25.6% | |
| Q3 2024 | -8.6% | +2.2% | +29.5% | |
| Q2 2024 | +7.2% | +8.6% | +8.4% | |
| Q1 2024 | +1.1% | -2.6% | -15.2% | |
| Q4 2023 | -5.4% | +8.0% | +12.6% | |
| Q3 2023 | -22.8% | -16.9% | +1.3% | |
| Q2 2023 | -14.7% | -10.2% | -10.1% | |
| Q1 2023 | +14.0% | +15.7% | +29.6% | |
| Q4 2022 | +2.4% | +7.6% | +13.5% | |
| Q3 2022 | +17.8% | +27.5% | +49.9% | |
| Q2 2022 | +18.2% | +15.0% | +6.5% | |
| Q1 2022 | +2.4% | -22.9% | -41.8% | |
| Q4 2021 | +7.3% | +29.9% | +30.6% | |
| Q3 2021 | -22.9% | -22.1% | -44.1% | |
| Q2 2021 | -9.1% | -10.8% | -8.6% | |
| Q1 2021 | -7.5% | -2.4% | -9.0% | |
| Q4 2020 | -10.4% | -15.0% | -13.7% | |
| Q3 2020 | +5.4% | -2.7% | +14.4% | |
| Q2 2020 | -13.3% | -8.4% | -9.9% | |
| Q1 2020 | -1.0% | +3.2% | +4.8% | |
| Q4 2019 | -2.8% | -6.3% | -28.2% | |
| Q3 2019 | +7.8% | +12.4% | +35.8% | |
| Q2 2019 | -9.6% | -7.6% | -11.3% | |
| Q1 2019 | +4.5% | +4.0% | -4.6% | |
| Q4 2018 | +0.4% | +2.9% | -27.5% | |
| Q3 2018 | -7.9% | -5.6% | -18.2% | |
| Q2 2018 | +13.4% | +12.4% | +37.6% | |
| Q1 2018 | +20.0% | +26.8% | +41.2% | |
| Q4 2017 | +7.8% | +1.6% | -0.8% | |
| Q3 2017 | -10.4% | -7.6% | -1.1% | |
| Q2 2017 | +17.4% | +7.7% | +19.3% | |
| Q1 2016 | +13.9% | +22.1% | +31.1% | |
| Q1 2017 | +13.9% | +22.1% | +31.1% | |
| Q1 2015 | +17.7% | +10.2% | +6.1% | |
| Q4 2016 | +17.7% | +10.2% | +6.1% | |
| Q4 2014 | +17.7% | +10.2% | +6.1% | |
| Q3 2015 | +7.6% | +2.1% | -11.1% | |
| Q3 2016 | +7.6% | +2.1% | -11.1% | |
| Q4 2015 | +6.8% | +3.9% | +31.8% | |
| Q2 2016 | +6.8% | +3.9% | +31.8% | |
| Q2 2015 | +6.8% | +3.9% | +31.8% | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro